BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7694905)

  • 1. Antidepressant and cognitive effects of twice- versus three-times-weekly ECT.
    Lerer B; Shapira B; Calev A; Tubi N; Drexler H; Kindler S; Lidsky D; Schwartz JE
    Am J Psychiatry; 1995 Apr; 152(4):564-70. PubMed ID: 7694905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response to right unilateral ECT in depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945].
    Heikman P; Katila H; Sarna S; Wahlbeck K; Kuoppasalmi K
    BMC Psychiatry; 2002; 2():2. PubMed ID: 11846888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes and cognitive function following electroconvulsive therapy in patients with severe depression.
    Han KY; Wang CM; Du CB; Qiao J; Wang YL; Lv LZ
    World J Psychiatry; 2023 Nov; 13(11):949-957. PubMed ID: 38073900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in cognitive impairment.
    Pellegrino LD; Peters ME; Lyketsos CG; Marano CM
    Curr Psychiatry Rep; 2013 Sep; 15(9):384. PubMed ID: 23933974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT.
    Shapira B; Tubi N; Drexler H; Lidsky D; Calev A; Lerer B
    Br J Psychiatry; 1998 Jan; 172():44-8. PubMed ID: 9534831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive Therapy Across Nations: A 2022 Survey of Practice.
    Rohde P; Noorani R; Feuer E; Lisanby SH; Regenold WT
    J ECT; 2024 Jun; 40(2):96-104. PubMed ID: 38109328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroceutical and Bioelectric Therapy: Its Advantages and Limitations.
    Jung B; Yang C; Lee SH
    Clin Psychopharmacol Neurosci; 2023 Feb; 21(1):19-31. PubMed ID: 36700309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlating electroconvulsive therapy response to electroencephalographic markers: Study protocol.
    Subramanian S; Labonte AK; Nguyen T; Luong AH; Hyche O; Smith SK; Hogan RE; Farber NB; Palanca BJA; Kafashan M;
    Front Psychiatry; 2022; 13():996733. PubMed ID: 36405897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroconvulsive therapy combined with lithium developed reversible pure anomic aphasia: a case report.
    Yang Q; Cheng X; Su Z; Sun L; Li M
    BMC Psychiatry; 2022 Oct; 22(1):663. PubMed ID: 36303177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and Duration of Course of ECT Sessions: An Appraisal of Recent Evidence.
    Thirthalli J; Naik SS; Kunigiri G
    Indian J Psychol Med; 2020; 42(3):207-218. PubMed ID: 32612324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of modified electroconvulsive therapy on the electroencephalogram of schizophrenia patients.
    Zhao L; Jiang Y; Zhang H
    Springerplus; 2016; 5(1):1063. PubMed ID: 27462511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Retrograde Autobiographical Memory Changes Following Electroconvulsive Therapy: Relationships between Individual, Treatment, and Early Clinical Factors.
    Martin DM; Gálvez V; Loo CK
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of modified electroconvulsive therapy on the cognitive function and blood parameters in female patients with schizophrenia.
    Jiang Y; Zhang H; Wang Z; Zhao L; Lv L
    Int J Clin Exp Med; 2015; 8(1):1349-55. PubMed ID: 25785136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy.
    Loo CK; Katalinic N; Smith DJ; Ingram A; Dowling N; Martin D; Addison K; Hadzi-Pavlovic D; Simpson B; Schweitzer I
    Int J Neuropsychopharmacol; 2014 Dec; 18(1):. PubMed ID: 25522389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed Onset and Prolonged ECT-Related Delirium.
    Hassamal S; Pandurangi A; Venkatachalam V; Levenson J
    Case Rep Psychiatry; 2013; 2013():840425. PubMed ID: 24078892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of therapeutic efficacy of ect and imipramine : a randomized controlled trial.
    Selvan CP; Mayur PM; Gangadhar BN; Janakiramaiah N; Subbakrishna DK; Murali N
    Indian J Psychiatry; 1999 Jul; 41(3):228-35. PubMed ID: 21455395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpharmacological, somatic treatments of depression: electroconvulsive therapy and novel brain stimulation modalities.
    Eitan R; Lerer B
    Dialogues Clin Neurosci; 2006; 8(2):241-58. PubMed ID: 16889109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse cognitive effects and ECT].
    Prapotnik M; Pycha R; Nemes C; König P; Hausmann A; Conca A
    Wien Med Wochenschr; 2006 Apr; 156(7-8):200-8. PubMed ID: 16823537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electroconvulsive therapy as maintenance therapy and for prevention of recurrence in psychiatric disorders and Parkinson disease].
    Willeit M; Praschak-Rieder N; Kasper S
    Wien Klin Wochenschr; 2003 May; 115(9):281-90. PubMed ID: 12793028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy.
    Segman RH; Shapira B; Gorfine M; Lerer B
    Psychopharmacology (Berl); 1995 Jun; 119(4):440-8. PubMed ID: 7480524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.